RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Juwon Park to Nanoparticles

This is a "connection" page, showing publications Juwon Park has written about Nanoparticles.
Connection Strength

0.395
  1. Lee HJ, Lee NK, Kim J, Kim J, Seo D, Shin HE, Kim J, Ahn JH, Kim SN, Kim HS, Park J, Park W, Hong KS, Park CG, Lee W. Sequential nanoparticle therapy targeting neutrophil hyperactivation to prevent neutrophil-induced pulmonary fibrosis. J Nanobiotechnology. 2025 May 26; 23(1):381.
    View in: PubMed
    Score: 0.155
  2. Shin HE, Giannakopoulos S, Park JD, Jang HJ, Park CG, Murphy SV, Park J, Verma S, Park W. Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation. J Control Release. 2025 Jun 10; 382:113736.
    View in: PubMed
    Score: 0.154
  3. Park J, Wysocki RW, Amoozgar Z, Maiorino L, Fein MR, Jorns J, Schott AF, Kinugasa-Katayama Y, Lee Y, Won NH, Nakasone ES, Hearn SA, K?ttner V, Qiu J, Almeida AS, Perurena N, Kessenbrock K, Goldberg MS, Egeblad M. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Sci Transl Med. 2016 10 19; 8(361):361ra138.
    View in: PubMed
    Score: 0.086
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support